A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies Meeting Abstract


Authors: Wilson, W. H.; Czuczman, M. S.; LaCasce, A. S.; Gerecitano, J. F.; Leonard, J. P.; Dunleavy, K.; Krivoshik, A. P.; Xiong, H.; Chiu, Y.; O'Connor, O. A.
Abstract Title: A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 456s
Language: English
ACCESSION: WOS:000208457403039
DOI: 10.1200/jco.2008.26.15_suppl.8511
PROVIDER: wos
Notes: Meeting Abstract: 8511 -- Source: Wos
Altmetric Score
MSK Authors